Literature DB >> 34907118

Heparin Binding Protein for the Early Diagnosis and Prognosis of Sepsis in the Emergency Department: The Prompt Multicenter Study.

Konstantinos Katsaros1, Georgios Renieris2, Asimina Safarika2, Evangelia-Maria Adami2, Theologia Gkavogianni2, George Giannikopoulos3, Nicky Solomonidi2, Stamatios Halvatzis2, Ioannis M Koutelidakis4, Nikolaos Tsokos5, Maroula Tritzali3, Pantelis Koutoukas6, Cristina Avgoustou2, Anil Vasishta7, Evangelos J Giamarellos-Bourboulis2.   

Abstract

BACKGROUND: The validation of new biomarkers for the diagnosis and risk stratification of patients with sepsis at an early point is essential for successful treatment. Recent publications prompted us to investigate of heparin binding protein (HBP) for the emergency department (ED) admissions.
MATERIALS AND METHODS: In this multicenter, cross-sectional study, HBP and procalcitonin (PCT) were measured within the first hour upon admission to the ED in plasma samples of 371 patients with signs of infection. Patients were classified into non-sepsis and sepsis by the Sepsis-3 definitions and were followed up for outcome.
RESULTS: HBP was significantly higher in patients with sepsis and was positively correlated to PCT and C-reactive protein, absolute neutrophil and monocyte counts, creatinine, bilirubin and lactate. Sensitivity, specificity, positive predictive value, and negative predictive value of HBP more than 19.8 ng/mL for the diagnosis of sepsis was 66.3%, 44.9%, 49.3%, and 62.2%, respectively; and for prediction of early death was 100%, 41.0%, 4.5%, and 100%, respectively. Single HBP and PCT could not predict 28-day mortality; this was performed with sensitivity, specificity, positive predictive value, and negative predictive value 44.8%, 81.8%, 17.3%, and 94.6% when used in combination.
CONCLUSION: Admission HBP can be used as a tool for the early diagnosis of sepsis and for the risk of early death in the ED.
Copyright © 2021 by the Shock Society.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34907118     DOI: 10.1097/SHK.0000000000001900

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  5 in total

1.  [Value of heparin-binding protein in the diagnosis of severe adenovirus pneumonia in children].

Authors:  Xiao-Yan Liu; Xiao-Fo Zhang; Jia Li; Fang Zhu; Qing-Le Yu; Song-Qing Wei; Man-Zhi Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022 Sept 15

Review 2.  Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression.

Authors:  Ren-Qi Yao; Chao Ren; Li-Yu Zheng; Zhao-Fan Xia; Yong-Ming Yao
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

3.  Multi-marker approach using C-reactive protein, procalcitonin, neutrophil CD64 index for the prognosis of sepsis in intensive care unit: a retrospective cohort study.

Authors:  Na Huang; Jing Chen; Yu Wei; Yongrui Liu; Kang Yuan; Jingli Chen; Mingfeng He; Nan Liu
Journal:  BMC Infect Dis       Date:  2022-07-30       Impact factor: 3.667

4.  Clinical value of serum sTREM-1 and HBP levels in combination with traditional inflammatory markers in diagnosing hospital-acquired pneumonia in elderly.

Authors:  Zhang Wang; Binbin Chang; Yong Zhang; Jieyu Chen; Fang Xie; Ying Xiang; Tingting Liu; Ying Li
Journal:  BMC Infect Dis       Date:  2022-10-04       Impact factor: 3.667

5.  A 29-MRNA HOST RESPONSE WHOLE-BLOOD SIGNATURE IMPROVES PREDICTION OF 28-DAY MORTALITY AND 7-DAY INTENSIVE CARE UNIT CARE IN ADULTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH SUSPECTED ACUTE INFECTION AND/OR SEPSIS.

Authors:  Antigone Kostaki; James W Wacker; Asimina Safarika; Nicky Solomonidi; Konstantinos Katsaros; George Giannikopoulos; Ioannis M Koutelidakis; Catherine A Hogan; Florian Uhle; Oliver Liesenfeld; Timothy E Sweeney; Evangelos J Giamarellos-Bourboulis
Journal:  Shock       Date:  2022-08-26       Impact factor: 3.533

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.